RT Journal Article
SR Electronic
T1 Why a Globally Fair COVID-19 Vaccination? An Analysis based on Agent-Based Simulation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.03.21264494
DO 10.1101/2021.10.03.21264494
A1 Kashif Zia
YR 2021
UL http://medrxiv.org/content/early/2021/10/04/2021.10.03.21264494.abstract
AB In this paper, an Agent-Based Model (ABM) is proposed to evaluate the impact of COVID-19 vaccination drive in different settings. The main focus is to evaluate the counter-effectiveness of disparity in vaccination drive among different regions / countries. The model proposed is simple yet novel in the sense that it captures the spatial transmission-induced activity into consideration, through which we are able to relate transmission model to the mutated variations of the virus. Some important what-if questions are asked in terms of number of deaths, and time required and percentage of population needed to be vaccinated before the pandemic is eradicate. The simulation results have revealed that it is necessary to maintain a global (rather than regional or country oriented) vaccination drive in case of a new pandemic or continual efforts against COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was used.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data was used.